Steward Partners Investment Advisory’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6K Buy
457
+130
+40% +$2.96K ﹤0.01% 3665
2026
Q1
$7K Hold
327
– – ﹤0.01% 3695
2025
Q4
$7K Sell
327
-17,589
-98% -$360K ﹤0.01% 3582
2025
Q3
$300K Buy
17,916
+17,865
+35,029% +$268K ﹤0.01% 1653
2025
Q2
$732 Sell
51
-10
-16% -$137 ﹤0.01% 3920
2025
Q1
$884 Hold
61
– – ﹤0.01% 3794
2024
Q4
$800 Sell
61
-71
-54% -$980 ﹤0.01% 3794
2024
Q3
$1.53K Buy
132
+42
+47% +$396 ﹤0.01% 3482
2024
Q2
$680 Buy
+90
New +$744 ﹤0.01% 3441
2023
Q1
– Sell
-58
Closed -$862 – 3379
2022
Q4
$862 Buy
+58
New +$946 ﹤0.01% 3136
2017
Q3
– Sell
-205
Closed -$12K – 1723
2017
Q2
$12K Hold
205
– – ﹤0.01% 1001
2017
Q1
$14K Buy
+205
New +$14.2K ﹤0.01% 854

Other funds holding MD

Steward Partners Investment Advisory's MD Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Pediatrix Medical (MD) stake by 40% in Q2 2026, buying an estimated $2.96K and bringing the position to 457 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3665.

Steward Partners Investment Advisory first reported a position in MD in Q1 2017 and has held it in 12 quarters since. The position peaked at $300K in Q3 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Steward Partners Investment Advisory held 457 shares of Pediatrix Medical worth $11.6K as of Q2 2026.
  • Steward Partners Investment Advisory bought 130 Pediatrix Medical shares in Q2 2026, an estimated $2.96K.
  • Pediatrix Medical made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3665 holding.
  • Steward Partners Investment Advisory first reported a position in Pediatrix Medical in Q1 2017 and has held it in 12 quarters since.
  • Steward Partners Investment Advisory's Pediatrix Medical position peaked at $300K in Q3 2025.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.